...
首页> 外文期刊>Drugs: education, prevention, and policy >Medicalizing cannabis-Science, medicine and policy, 1950-2004: An overview of a work in progress
【24h】

Medicalizing cannabis-Science, medicine and policy, 1950-2004: An overview of a work in progress

机译:大麻医学化-科学,医学和政策,1950-2004年:正在进行的工作概述

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cannabis has been the subject of much policy and media attention in the last few years and the 2004 legal changes under the Misuse of Drugs Act in the UK, were widely, although incorrectly, presented as liberalization or legalization of the drug. Current debates over the classification of cannabis as Class C or B serve to emphasize the controversies that surround the drug. This paper provides an overview of a Wellcome Trust three-year project that is currently in progress. Framed as a history of science and policy making, the project aims to study the process whereby boundaries shift between illicit 'drug' and licit 'medicine' and the issues and interests that are involved in that transaction. Specifically, the project aims to analyse the trajectory of research since the 1950s, the interests involved, in particular the role of scientific research and allied professions; industry; drug technology; and lay knowledge and user activism. It aims to analyse the interaction of science and medicine with policy through the examination of the policy role of expert committees and their membership. The impact of international agencies will also be considered. Lastly, it will assess the overall impact of medicalization on the policy environment. Standard historical methodology will be applied and a wide variety of published and archival source material, as well as semi-structured oral history interviews, will be utilized.
机译:过去几年来,大麻一直是许多政策和媒体关注的主题,根据英国《滥用药物法》(Nasuse of Misuse of Act),2004年的法律变更被广泛地(尽管错误地)表示为毒品的自由化或合法化。当前有关将大麻分类为C类或B类的辩论旨在强调围绕该药物的争议。本文概述了正在进行中的Wellcome Trust三年项目。该项目以科学和政策制定的历史为框架,旨在研究非法“药物”与合法“药物”之间界限转移的过程以及涉及该交易的问题和利益。具体而言,该项目旨在分析1950年代以来的研究轨迹,所涉及的利益,尤其是科学研究和相关专业的作用;行业;药物技术;并奠定知识和用户积极性。它旨在通过审查专家委员会的政策角色及其成员来分析科学与医学与政策的相互作用。也将考虑国际机构的影响。最后,它将评估医疗化对政策环境的总体影响。将采用标准的历史方法,并使用各种已出版和存档的原始资料,以及半结构化的口述历史访谈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号